SAB Biotherapeutics Inc.

1.19
-0.06 (-4.80%)
At close: Apr 03, 2025, 3:59 PM
1.22
2.17%
After-hours: Apr 03, 2025, 06:02 PM EDT

SAB Biotherapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
1.32M 2.24M 23.9M 60.88M 55.24M 3.44M
n/a 3.75M 3.29M 1.65M n/a n/a
1.32M -1.51M 20.61M 59.22M 55.24M 3.44M
-42.91M -38.08M -28.92M -13.39M 20.56M -8.67M
1.29M 584.97K 71.07K 23.11K 26.13K 113.13K
-34.11M -42.19M -18.72M -17.14M 20.12M -8.99M
-34.11M -42.19M -18.74M -17.44M 20.12M -9.42M
13.98M 20.05M 16.38M 17.09M 6.77M 4.1M
30.25M 16.52M 36.44M 57.18M 27.91M 8.02M
n/a n/a -23.9M -60.88M 4K 2.59K
44.23M 36.57M 28.92M 13.39M 34.68M 12.12M
-318.4K 315.28K 301.58K 294.46K 469.15K 428.48K
n/a -3.75M n/a n/a n/a n/a
44.23M 40.31M 28.92M 13.39M 34.68M 12.12M
n/a n/a 25.63K 299.95K 473.15K 431.07K
9.26M 5.52M 4.35M 2.73M 2.54M 43.47M
9.26M 5.52M 4.35M 2.73M 2.7M 43.47M
-3.68 -7.64 -4.31 -6.38 7.92 -0.22
-3.68 -7.64 -4.31 -6.38 7.45 -0.22
-42.91M -38.13M -15.12M -15.2M 21.14M -8.23M
-34.42M -41.88M -18.41M -16.85M 20.59M -8.56M
n/a 3.75M 3.29M 1.65M 548.18K 323.41K